Douglas Deeth

Douglas Deeth

Direttore/Membro del Consiglio presso CIPHER PHARMACEUTICALS INC.

Patrimonio netto: 26 608 $ in data 31/08/2026

78 anni
Health Technology
Commercial Services
Consumer Services

Profilo

Mr. Douglas N.
Deeth
is an Independent Director at Cipher Pharmaceuticals, Inc., a Senior Partner at Deeth Williams Wall LLP, a Member at Ontario Bar Association and a Member at Intellectual Property Institute of Canada.
He is on the Board of Directors at Cipher Pharmaceuticals, Inc. and IMBiotechnologies Ltd. Mr. Deeth was previously employed as an Independent Non-Executive Director by Advanz Pharma Corp., an Independent Director by Acerus Pharmaceuticals Corp., and a President-Intellectual Property Law by The Canadian Bar Association.
He received his undergraduate degree from The University of Waterloo and a graduate degree from the University of Toronto.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValutazioneData di valutazione
24/06/2026 2.689 ( 0,01% ) 26 608 $ 31/08/2026

Posizioni attive di Douglas Deeth

SocietàPosizioneInizio
CIPHER PHARMACEUTICALS INC. Direttore/Membro del Consiglio 21/06/2023
Corporate Officer/Principal 02/08/2011
Corporate Officer/Principal 08/08/2011
Corporate Officer/Principal 01/01/1976
Direttore/Membro del Consiglio 01/10/2010

Precedenti posizioni note di Douglas Deeth

SocietàPosizioneFine
ADVANZ PHARMA CORP. LIMITED Direttore/Membro del Consiglio 06/09/2018
Corporate Officer/Principal -
ACERUS PHARMACEUTICALS CORPORATION Direttore/Membro del Consiglio -
Vedi nel dettaglio l'esperienza di Douglas Deeth

Formazione di Douglas Deeth

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

67

Relazioni di 1° grado

10

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private10

Health Technology

Consumer Services

Consumer Services

Commercial Services

Commercial Services

Commercial Services

Health Technology

Health Technology

Commercial Services

Health Technology

  1. Mercati
  2. Insiders
  3. Douglas Deeth